|
|
Gene Symbol |
IGF1 |
|
Aliases |
IGF, IGF-I, IGFI, MGF |
|
Entrez Gene ID |
|
|
Gene Name |
Insulin like growth factor 1 |
|
Chromosomal Location |
12q23.2 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene is similar to insulin in function and structure and is a member of a family of proteins involved in mediating growth and development. The encoded protein is processed from a precursor, bound by a specific receptor, and secreted. Defects in this gene are a cause of insulin-like growth factor I deficiency. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Sep 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000187 |
Biological process |
Activation of MAPK activity |
IMP |
22351760 |
GO:0001501 |
Biological process |
Skeletal system development |
TAS |
10448861 |
GO:0001775 |
Biological process |
Cell activation |
IDA |
22797923 |
GO:0007165 |
Biological process |
Signal transduction |
TAS |
10448861 |
GO:0007265 |
Biological process |
Ras protein signal transduction |
TAS |
10848592 |
GO:0007517 |
Biological process |
Muscle organ development |
TAS |
10448861 |
GO:0008283 |
Biological process |
Cell proliferation |
IMP |
1847964, 9714146 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IDA |
7688386, 9722506, 12746903 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IMP |
19578119 |
GO:0009408 |
Biological process |
Response to heat |
IDA |
11404306 |
GO:0009441 |
Biological process |
Glycolate metabolic process |
TAS |
10448861 |
GO:0010468 |
Biological process |
Regulation of gene expression |
IMP |
21543511 |
GO:0010560 |
Biological process |
Positive regulation of glycoprotein biosynthetic process |
IMP |
9564845 |
GO:0010613 |
Biological process |
Positive regulation of cardiac muscle hypertrophy |
IDA |
19654000 |
GO:0010613 |
Biological process |
Positive regulation of cardiac muscle hypertrophy |
IMP |
19933931 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IGI |
22635104 |
GO:0010629 |
Biological process |
Negative regulation of gene expression |
IDA |
29167509 |
GO:0014065 |
Biological process |
Phosphatidylinositol 3-kinase signaling |
IMP |
24508636 |
GO:0014068 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
IDA |
7688386 |
GO:0014834 |
Biological process |
Skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration |
IDA |
17531227 |
GO:0014896 |
Biological process |
Muscle hypertrophy |
IMP |
10191278 |
GO:0014904 |
Biological process |
Myotube cell development |
IDA |
17531227 |
GO:0014911 |
Biological process |
Positive regulation of smooth muscle cell migration |
IDA |
10766744 |
GO:0030166 |
Biological process |
Proteoglycan biosynthetic process |
IDA |
12746903 |
GO:0030166 |
Biological process |
Proteoglycan biosynthetic process |
IMP |
9564845 |
GO:0030335 |
Biological process |
Positive regulation of cell migration |
IMP |
24508636 |
GO:0032148 |
Biological process |
Activation of protein kinase B activity |
IMP |
22351760 |
GO:0032691 |
Biological process |
Negative regulation of interleukin-1 beta production |
IGI |
27277332 |
GO:0032720 |
Biological process |
Negative regulation of tumor necrosis factor production |
IGI |
27277332 |
GO:0034392 |
Biological process |
Negative regulation of smooth muscle cell apoptotic process |
IDA |
16942485 |
GO:0035630 |
Biological process |
Bone mineralization involved in bone maturation |
IDA |
16433617 |
GO:0040014 |
Biological process |
Regulation of multicellular organism growth |
IEP |
8421089 |
GO:0042104 |
Biological process |
Positive regulation of activated T cell proliferation |
IDA |
15694994 |
GO:0042531 |
Biological process |
Positive regulation of tyrosine phosphorylation of STAT protein |
IDA |
9722506 |
GO:0043066 |
Biological process |
Negative regulation of apoptotic process |
IMP |
11949853 |
GO:0043388 |
Biological process |
Positive regulation of DNA binding |
IDA |
19654000 |
GO:0043410 |
Biological process |
Positive regulation of MAPK cascade |
IDA |
19654000 |
GO:0043491 |
Biological process |
Protein kinase B signaling |
IMP |
24508636 |
GO:0043568 |
Biological process |
Positive regulation of insulin-like growth factor receptor signaling pathway |
IDA |
7688386, 10766744 |
GO:0045445 |
Biological process |
Myoblast differentiation |
IDA |
17531227 |
GO:0045669 |
Biological process |
Positive regulation of osteoblast differentiation |
IDA |
16433617 |
GO:0045725 |
Biological process |
Positive regulation of glycogen biosynthetic process |
IDA |
21076856 |
GO:0045821 |
Biological process |
Positive regulation of glycolytic process |
IDA |
7688386 |
GO:0045840 |
Biological process |
Positive regulation of mitotic nuclear division |
IDA |
7188854, 10644978 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
9722506, 19654000 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IMP |
15059951 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
16433617 |
GO:0046326 |
Biological process |
Positive regulation of glucose import |
IDA |
21076856 |
GO:0046579 |
Biological process |
Positive regulation of Ras protein signal transduction |
IDA |
9722506 |
GO:0048009 |
Biological process |
Insulin-like growth factor receptor signaling pathway |
IMP |
19578119, 22351760 |
GO:0048015 |
Biological process |
Phosphatidylinositol-mediated signaling |
IDA |
7692086 |
GO:0048146 |
Biological process |
Positive regulation of fibroblast proliferation |
IDA |
7188854 |
GO:0048661 |
Biological process |
Positive regulation of smooth muscle cell proliferation |
IDA |
10766744, 16942485 |
GO:0050679 |
Biological process |
Positive regulation of epithelial cell proliferation |
IDA |
7188854 |
GO:0050714 |
Biological process |
Positive regulation of protein secretion |
IMP |
9564845 |
GO:0050731 |
Biological process |
Positive regulation of peptidyl-tyrosine phosphorylation |
IDA |
7782332, 22635104 |
GO:0050821 |
Biological process |
Protein stabilization |
IMP |
9564845 |
GO:0051450 |
Biological process |
Myoblast proliferation |
IDA |
17531227 |
GO:0060283 |
Biological process |
Negative regulation of oocyte development |
IMP |
21543511 |
GO:0061051 |
Biological process |
Positive regulation of cell growth involved in cardiac muscle cell development |
IDA |
24117217 |
GO:0061051 |
Biological process |
Positive regulation of cell growth involved in cardiac muscle cell development |
IGI |
24117217 |
GO:0070371 |
Biological process |
ERK1 and ERK2 cascade |
IMP |
24508636 |
GO:0070886 |
Biological process |
Positive regulation of calcineurin-NFAT signaling cascade |
IDA |
19654000 |
GO:0150079 |
Biological process |
Negative regulation of neuroinflammatory response |
IGI |
27277332 |
GO:1902430 |
Biological process |
Negative regulation of amyloid-beta formation |
IGI |
27277332 |
GO:1904075 |
Biological process |
Positive regulation of trophectodermal cell proliferation |
IMP |
24508636 |
GO:1904646 |
Biological process |
Cellular response to amyloid-beta |
IGI |
22635104 |
GO:1904707 |
Biological process |
Positive regulation of vascular smooth muscle cell proliferation |
IMP |
26166810 |
GO:1905460 |
Biological process |
Negative regulation of vascular associated smooth muscle cell apoptotic process |
IMP |
26166810 |
GO:2000679 |
Biological process |
Positive regulation of transcription regulatory region DNA binding |
IDA |
15059951 |
GO:2001237 |
Biological process |
Negative regulation of extrinsic apoptotic signaling pathway |
IDA |
16942485 |
GO:0005576 |
Cellular component |
Extracellular region |
NAS |
14718574 |
GO:0005615 |
Cellular component |
Extracellular space |
IDA |
7188854, 11404306, 17119061, 25152160 |
GO:0016942 |
Cellular component |
Insulin-like growth factor binding protein complex |
IC |
10766744 |
GO:0035867 |
Cellular component |
Alphav-beta3 integrin-IGF-1-IGF1R complex |
IDA |
19578119 |
GO:0042567 |
Cellular component |
Insulin-like growth factor ternary complex |
IDA |
9497324 |
GO:0005158 |
Molecular function |
Insulin receptor binding |
IPI |
8452530 |
GO:0005159 |
Molecular function |
Insulin-like growth factor receptor binding |
IDA |
19578119 |
GO:0005159 |
Molecular function |
Insulin-like growth factor receptor binding |
IMP |
1847964, 2967174 |
GO:0005159 |
Molecular function |
Insulin-like growth factor receptor binding |
IPI |
8452530 |
GO:0005178 |
Molecular function |
Integrin binding |
IDA |
19578119, 22351760 |
GO:0005179 |
Molecular function |
Hormone activity |
IDA |
7188854 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
8452530, 10766744, 15642270, 16924115, 21645859, 22578544, 26027733 |
|
Protein Information |
|
Protein Name |
Insulin-like growth factor I, insulin-like growth factor 1 (somatomedin C), insulin-like growth factor IB, mechano growth factor, somatomedin-C |
|
Function |
The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exocytosis of IGF1 is required for sensory perception of smell in the olfactory bulb (By similarity). Acts as a ligand for IGF1R. Binds to the alpha subunit of IGF1R, leading to the activation of the intrinsic tyrosine kinase activity which autophosphorylates tyrosine residues in the beta subunit thus initiatiating a cascade of down-stream signaling events leading to activation of the PI3K-AKT/PKB and the Ras-MAPK pathways. Binds to integrins ITGAV:ITGB3 and ITGA6:ITGB4. Its binding to integrins and subsequent ternary complex formation with integrins and IGFR1 are essential for IGF1 signaling. Induces the phosphorylation and activation of IGFR1, MAPK3/ERK1, MAPK1/ERK2 and AKT1 |
|
|
|
|
|
UniProt |
|
|
PDB |
2DSQ, 1WQJ, 2DSP, 2DSR, 1H59, 4XSS, 5U8Q, 1B9G, 1BQT, 1GF1, 1GZR, 1GZY, 1GZZ, 1H02, 1IMX, 1PMX, 1TGR, 2GF1, 3GF1, 3LRI, 6FF3 |
|
Pfam |
Pfam Accession |
Pfam ID |
PF00049 |
Insulin |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000268035 |
P08069 |
P08069 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Hypertensive disease |
|
Diabetic Cardiomyopathies |
|
Myocardial Ischemia |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Microcephaly |
|
Russell-Silver syndrome |
|
Digestive System Diseases |
Crohn Disease |
|
Liver Diseases |
|
Cholestasis |
|
Hepatitis |
|
Colitis |
|
Enteritis |
|
Endocrine System Diseases |
Precocious Puberty |
|
Ketosis-prone diabetes |
|
Acromegaly |
|
Diabetes Mellitus |
|
Brittle diabetes |
|
PCOS |
|
Eye Diseases |
Corneal Diseases |
|
Immune System Diseases |
Autoimmune Diabetes |
|
Neoplasms |
Prostate cancer |
|
Breast Cancer |
|
Bladder Cancer |
|
Adenoma |
|
Skin Cancer |
|
Pituitary Neoplasms |
|
Nervous System Diseases |
Brain Infarction |
|
Cerebral Artery Infarction |
|
Neuropathy |
|
Demyelinating Diseases |
|
Middle Cerebral Artery Syndrome |
|
Cerebral Thrombosis |
|
Nutritional and Metabolic Diseases |
Osteopenia |
|
Insulin-Like Growth Factor I Deficiency |
|
Metabolic Bone Disorder |
|
Psychiatric/Brain disorders |
Bipolar Disorder |
|
Mental Depression |
|
Delirium |
|
Alzheimer Disease |
|
Autistic Disorder |
|
Senile Dementia |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Kidney Insufficiency |
|
Kidney Failure |
|
Reproductive disorders |
Female Urogenital Diseases |
|
Endometriosis |
|
Endometrioma |
|
Preeclampsia |
|
Respiratory Tract Diseases |
Pulmonary Fibrosis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
IGFBP-1 |
hypopituitarism |
|
|
Related
|
women with PCOS (n = 10), hypopituitarism (n = 12) and normal controls (n = 10) |
Patients with PCOS could be separated into those with high LH and those with high insulin levels. It was concluded that women with PCOS have normal serum IGF-1 concentrations but IGFBP-1 levels, regulated by insulin, are low. Hyperinsulinaemia and raised LH are independently capable of stimulating ovarian androgen production. Growth factors may have an important role in the pathogenesis of PCOS. |
|
VEGF |
|
|
|
Related
|
50 infertile women with PCOS and 20healthy control |
Higher serum levels of VEGF and IGF-1 in PCOS women may be related to the increased vascularity that underlies the increased blood flow demonstrated by Doppler blood flow measurements in these women. |
|
leptin |
hyperinsulinemia |
|
|
Related
|
46 PCOS-HI and 46 PCOS-NHI |
The leptin and IGF-1 may contribute to the pathogenesis of PCOS, but the relationship between leptin, IGF-1 and hyperinsulinemia needs more researches to confirm. |
|
IGFBP-3 |
|
|
|
Related
|
11 women with PCOS and 6 matched ovulatory controls |
PCOS may be more sensitive to the effects of octreotide in decreasing IGF-1 and increasing IGFBP-3 |
|
|
|
|
|
Related
|
9 women with PCOS and one patient with multicystic ovaries |
IGF1 has a paracrine role in the regulation of ovarian function in the human female. |
|
INS |
hyperandrogenism and hyperinsulinmia |
|
|
Related
|
48 patients with PCOS (24 were obese BMI > 25 and 24 nonobese) and 10 control |
The findings suggest that the women with PCOS have HI, since INS may play an important role in hyperandrogenism by upregulating IGF-1 system in ovary. |
|
|
|
|